For instance, some studies showed unfavorable outcomes in MDS mutant BCOR/BCORL1 [64,101,102], while another revealed a neutral impact even after adjustment to age and IPSS-R risk score [81]. This evidence concerns the gene BCORL1 and myelodysplastic syndrome.